The DOI matches its Crossref record; 69 of the 75 references it cites were found in a registry or an index; 15 of the 87 sources its claims cite were checked for support.
Analysis of the efficacy, safety, and regulatory status of novel forms of creatine
Open accessAbstract
Creatine has become one of the most popular dietary supplements in the sports nutrition market. The form of creatine that has been most extensively studied and commonly used in dietary supplements is creatine monohydrate (CM). Studies have consistently indicated that CM supplementation increases muscle creatine and phosphocreatine concentrations by approximately 15-40%, enhances anaerobic exercise capacity, and increases training volume leading to greater gains in strength, power, and muscle mass. A number of potential therapeutic benefits have also been suggested in various clinical populations. Studies have indicated that CM is not degraded during normal digestion and that nearly 99% of orally ingested CM is either taken up by muscle or excreted in urine. Further, no medically significant side effects have been reported in literature. Nevertheless, supplement manufacturers have continually introduced newer forms of creatine into the marketplace. These newer forms have been purported to have better physical and chemical properties, bioavailability, efficacy, and/or safety profiles than CM. However, there is little to no evidence that any of the newer forms of creatine are more effective and/or safer than CM whether ingested alone and/or in combination with other nutrients. In addition, whereas the safety, efficacy, and regulatory status of CM is clearly defined in almost all global markets; the safety, efficacy, and regulatory status of other forms of creatine present in today's marketplace as a dietary or food supplement is less clear.
Overview
CoChat Summary
TL;DR
This review compares creatine monohydrate (CM) with newer creatine forms and concludes that CM is the most studied, effective, and stable form, with no medically significant side effects reported, while newer forms lack evidence of superior efficacy or safety. It also finds that most alternative creatine forms have unclear or unauthorized regulatory status in major markets.
Key findings
- CM supplementation consistently increases muscle creatine/phosphocreatine by approximately 15–40%, enhances anaerobic exercise capacity, and increases training volume leading to greater gains in strength, power, and muscle mass; nearly 99% of orally ingested CM is either taken up by muscle or excreted in urine, and no medically significant side effects have been reported.
- Newer forms generally contain less creatine than CM (CM 87.9%; creatine ethyl ester 82.4%; creatine citrate 66%; creatine pyruvate 60%; creatine anhydrous 100%), and some are less stable: tricreatine citrate showed creatinine levels of 770 ppm at 40°C after 28 days, whereas CM showed no degradation at 40°C for more than 3 years (creatinine under 67 ppm) and only 106 ppm at 60°C after 44 months.
- Bioavailability/ergogenic comparisons were mixed: creatine pyruvate had 17% higher mean peak and 14% higher AUC plasma creatine than CM in six subjects; whole-body creatine retention was 61 ± 15% for CM, 80 ± 11% for CM plus dextrose, and 63 ± 13% for effervescent tricreatine citrate (no significant CM vs. tricreatine citrate difference); liquid creatine had no effect on muscle phosphagen levels, while CM increased muscle free creatine by 31 ± 28%; creatine ethyl ester increased serum creatinine and raised muscle total creatine less than CM.
- Regulatory status: CM is approved or grandfathered in the USA, Canada, EU, Japan, South Korea, and Brazil; Japan also approved creatine citrate and creatine pyruvate for import; the FDA objected to creatine ethyl ester, creatine-L-carnitinate, and tricreatine orotate, with no decision posted for creatine pyruvate; no other forms were approved in Canada, EU, South Korea, or Brazil.
Methods
- Systematic review of literature on creatine forms available globally as dietary supplements, food supplements, or natural health products; Medline searches used creatine search terms plus technical/performance aspects (e.g., solubility, stability, bioavailability, performance), along with patent searches of WIPO, the European Patent Office, the Japan Patent Office, and the United States Patent and Trademark Office.
- Regulatory assessment accessed websites of the US FDA, Health Canada, European Commission, Japan Ministry of Health, Labor and Welfare, and Korea Food and Drug Administration; Brazil’s ANVISA is also discussed in the regulatory section.
Limitations
- Stated in the paper: there is little to no evidence that newer forms are more effective or safer than CM; basic safety data on new forms are lacking; public health implications of unsanctioned forms are unknown; more research is needed (e.g., for d-pinitol, Russian tarragon, and creatine pyruvate); and some regulatory decisions may be pending.
- Evident from the text: several included studies are small (e.g., six subjects in the plasma kinetics study; 16 males in the retention study; 24–30 participants in training studies), some comparisons lack head-to-head CM controls (e.g., creatine citrate studies did not compare to CM), and the review does not describe formal inclusion/exclusion criteria, risk-of-bias assessment, or quantitative synthesis.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures













Verification
Claims the paper makes
13 Valid · 6 Not valid · 54 Not checked · 87 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“As stated previously, CEE supplementation did not promote greater total muscle creatine levels in comparison to placebo.”
§ Analysis of the efficacy, safety, and regulatory status of novel forms of creatine > Ergogenic properties > Creatine ester
What the sources say
- Disputedcites Spillane et al. 2009 sourceExperimental — accuracy not yet measured
The Results (Muscle creatine, Figure 2) report significantly higher total muscle creatine in the CEE group than in the placebo group (p = 0.041), contrary to the claim. The Discussion (Serum and Muscle Creatine) says CEE was not significantly different from placebo, so our copy is internally inconsistent; the reported result supports the contrary conclusion. (LLM, conf=0.84)
Checked by a reasoning model — may be wrong.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
Every source the paper cites for this claim was checked and supports it.
In the paper
“The researchers found that serum creatinine levels were significantly increased in the CEE group after 6, 27, and 48 days of supplementation indicating less efficient bioavailability.”
§ Analysis of the efficacy, safety, and regulatory status of novel forms of creatine > Bioavailability
What the sources say
- Supportedcites Spillane et al. 2009 source
The Results (Serum creatinine; page not indicated) report significant elevations in the CEE group at days 6, 27, and 48. The Discussion (Serum Creatinine; page not indicated) interprets the creatinine and muscle-creatine findings as indicating that CEE does not offer superior muscle creatine uptake to creatine monohydrate. (LLM, conf=0.90)
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Dietary creatine is presumed to have high bioavailability since intestinal absorption of CM is already close to 100% (Deldicque et al. 2008).”
§ Analysis of the efficacy, safety, and regulatory status of novel forms of creatine > Bioavailability
What the sources say
- Supportedcites Deldicque et al. 2008 source
The Protocol identifies the creatine used in both the aqueous solution and food bars as creatine monohydrate. The Discussion reports complete gastrointestinal absorption after a week of supplementation and says arterial bioavailability likely approaches 100%, supporting the claim's cautious wording. Page numbers are not available in our copy. (LLM, conf=0.92)
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Studies have shown that Russian tarragon (RT) appears to have antihyperglycemic activity when combined with CM ingestion (Jäger et al. 2008a; Wang et al. 2008).”
§ Analysis of the efficacy, safety, and regulatory status of novel forms of creatine > Bioavailability
What the sources say
- Partly supportedcites Jäger et al. 2008a sourceExperimental — accuracy not yet measured
The Background states that Russian tarragon extract has shown antihyperglycemic activity. The Methods and Results describe its co-administration with creatine monohydrate, but this study measured plasma creatine, not whether the combination lowered blood glucose. The claim's combined-treatment qualifier is therefore not established. (LLM, conf=0.88)
- Partly supportedcites Wang et al. 2008 sourceExperimental — accuracy not yet measured
The Introduction reports that Russian tarragon extract lowered blood glucose in diabetic mice, and the Results report increased glucose uptake in cultured human skeletal muscle cells. Neither section addresses its effect when combined with CM ingestion, so the combination-specific claim is unsupported by this paper. (LLM, conf=0.89)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Additionally, co-ingesting creatine with different types of protein may have differential effects on gains in fat-free mass and/or training adaptations (Kerksick et al. 2007; Cribb et al. 2007b).”
§ Analysis of the efficacy, safety, and regulatory status of novel forms of creatine > Ergogenic properties > Creatine-containing nutritional formulations
What the sources say
- Not checked — no full text of the sourcecites Kerksick et al. 2007 source
- Partly supportedcites Cribb et al. 2007b sourceExperimental — accuracy not yet measured
The Abstract describes a creatine–whey protein group and measures lean mass and training adaptations. But the study did not compare creatine co-ingested with different types of protein: its other creatine group received carbohydrate. The Body composition section reports no significant lean-mass difference between those two groups, so this paper does not establish the proposed differential effect. (LLM, conf=0.86)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
81 more claims · 4 with their cited sources checked
Create a free account to see all 160 claims and to verify the 1 reference still open.
- It may state two separate claims as one. 60
- Probably not a substantial claim. 17
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mixing creatine in higher temperature solution increase solubility, which is the reason why initial studies administered creatine in hot tea [35, 60, 103, 104, 123, 182] but the solubility has no influence on tissue uptake [187].”
From Common questions and misconceptions about creatine supplementation: what does the scientific evidence really show? (2021) · cites this paper as [187]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“less than 1% of creatine monohydrate is degraded to creatinine during the digestive process and creatine is taken up by tissue or excreted in urine after ingestion [60, 185–187].”
From Common questions and misconceptions about creatine supplementation: what does the scientific evidence really show? (2021) · cites this paper as [187]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The degradation of creatine can be reduced or halted by lowering the pH under 2.5 or increasing the pH above 12.1 [187].”
From Common questions and misconceptions about creatine supplementation: what does the scientific evidence really show? (2021) · cites this paper as [187]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, the gold standards for measuring the effects of creatine supplementation on target tissues are through magnetic resonance spectroscopy (MRS), muscle biopsy, stable isotope tracer studies, and/or whole body creatine retention assessed by measuring the difference between creatine intake and urinary excretion of creatine”
From International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine (2017) · cites this paper as [53]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While some have suggested that individuals with pre-existing renal disease consult with their physician prior to creatine supplementation in an abundance of caution, these studies and others have led researchers to conclude that there is no compelling evidence that creatine supplementation negatively affects renal function in healthy or clinical populations [5, 6, 22, 53, 259, 266, 267].”
From International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine (2017) · cites this paper as [53]
Experimental — accuracy not yet measured
37 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“This analysis allowed for a comparison of ingesting recommended doses of liquid creatine to a placebo, as well as seven times the amount recommended by the manufacturer that would purportedly provide an equal amount of CM.”
§ Analysis of the efficacy, safety, and regulatory status of novel forms of creatine > Bioavailability
Reported 7 · recomputed 8
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Analysis of the efficacy, safety, and regulatory status of novel forms of creatine > Bioavailability
“Spillane et al. (2009) compared the effects of supplementing the diet with a placebo, CM, or CEE during 42 days of training.”
§ Analysis of the efficacy, safety, and regulatory status of novel forms of creatine > Bioavailability
“The researchers found that serum creatinine levels were significantly increased in the CEE group after 6, 27, and 48 days of supplementation indicating less efficient bioavailability.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Analysis of the efficacy, safety, and regulatory status of novel forms of creatine > Bioavailability
“This amounted to whole body creatine retention of 61 ± 15% for the CM group, 80 ± 11% for the CM plus dextrose group, and 63 ± 13% for the effervescent TCC group.”
§ Analysis of the efficacy, safety, and regulatory status of novel forms of creatine > Bioavailability
“an effervescent creatine supplement consisting of 5 g of TCC (66% creatine) plus 18 g dextrose four times/day for 3 days. Creatine retention was estimated by subtracting total urinary creatine excretion from total supplemental creatine intake over the 3-day period. Results revealed that average daily creatine retention over the 3-day period was 12.2 ± 1.3, 16.1 ± 2.2, and 12.6 ± 2.5 g/day for the CM, CM with dextrose, and effervescent TCC groups, respectively.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Analysis of the efficacy, safety, and regulatory status of novel forms of creatine > Summary
“No medically significant side effects have been reported from CM supplementation despite the widespread worldwide use and the regulatory status of CM not being well established.”
§ Analysis of the efficacy, safety, and regulatory status of novel forms of creatine > Regulatory status > Analysis
“The legal and regulatory status of CM is unequivocal in the major global markets for dietary or food supplements.”
Citations
Cites
Arzneimittelforschung: Erstanwendung am Menschen in der Phase I
Miletzki, B., & Gleiter, C. H. (2005) · Bundesgesundheitsblatt Gesundheitsforsch.Gesundheitsschutz · doi:10.1007/s00103-005-1024-7 · Cited by 9,355
Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation
Harris, R. C., Söderlund, K., & Hultman, E. (1992) · Clinical Science · doi:10.1042/cs0830367 · Cited by 1,168
Muscle creatine loading in men
Hultman, E., Soderlund, K., Timmons, J. A., Cederblad, G., & Greenhaff, P. L. (1996) · Journal of Applied Physiology · doi:10.1152/jappl.1996.81.1.232 · Cited by 822
Effects of creatine supplementation on body composition, strength, and sprint performance
KREIDER, R. B., FERREIRA, M., WILSON, M., GRINDSTAFF, P., PLISK, S., REINARDY, J., CANTLER, E., & ALMADA, A. L. (1998) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-199801000-00011 · Cited by 430
Self-citationISSN exercise & sport nutrition review: research & recommendations
Kreider, R. B., Wilborn, C. D., Taylor, L., Campbell, B., Almada, A. L., Collins, R., Cooke, M., Earnest, C. P., Greenwood, M., Kalman, D. S., et al. (2010) · Journal of the International Society of Sports Nutrition · doi:10.1186/1550-2783-7-7 · Cited by 428
Self-citationPerformance and muscle fiber adaptations to creatine supplementation and heavy resistance training
VOLEK, J. S., DUNCAN, N. D., MAZZETTI, S. A., STARON, R. S., PUTUKIAN, M., G??MEZ, A. L., PEARSON, D. R., FINK, W. J., & KRAEMER, W. J. (1999) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-199908000-00011 · Cited by 366
International Society of Sports Nutrition position stand: creatine supplementation and exercise
Buford, T. W., Kreider, R. B., Stout, J. R., Greenwood, M., Campbell, B., Spano, M., Ziegenfuss, T., Lopez, H., Landis, J., & Antonio, J. (2007) · Journal of the International Society of Sports Nutrition · doi:10.1186/1550-2783-4-6 · Cited by 341
Self-citationGreen, A. L., Hultman, E., Macdonald, I. A., Sewell, D. A., & Greenhaff, P. L. (1996) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1996.271.5.e821 · Cited by 294
Effects of Supplement Timing and Resistance Exercise on Skeletal Muscle Hypertrophy
CRIBB, P. J., & HAYES, A. (2006) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000233790.08788.3e · Cited by 270
Effects of creatine supplementation on performance and training adaptations
Kreider, R. B. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/a:1022465203458 · Cited by 264
Self-citation
Research works printed but not linked: 7
- Greenhaff P (1997a) Creatine supplementation and implications for exercise performance. In: Jeudendrup A, Brouns M, Brouns F (eds) Advances in training and nutrition for endurance sports. Novartis Nutrition Research Unit, Maasticht
- Greenhaff P, Bodin K, Harris R, Hultman E, Jones DG, McIntyre D, Soderlund K, Turner DL (1993) The influence of oral creatine supplementation on muscle phosphocreatine resynthesis following intense contraction in man. J Physiol 467:75P
- Harris RC, Soderlund K, Hultman E (1992b) Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation. Clin Sci (Lond) 83(3):367–374 · DOI · Paper page
- Kreider RB, Klesges RC, Lotz D, Davis M, Cantler E, Harmon-Clayton K, Dudley R, Grindstaff P, Ramsey L, Bullen D, Wood L, Almada A (1999) Effects of nutritional supplementation during off-season college football training on body composition and strength. J Exerc Physiol online 2(2):24–39
- Kreider RB, Willoughby DS, Greenwood M, Parise G, Payne E, Tarnopolsky MA (2003b) Effects of serum creatine supplementation on muscle creatine content. J Exerc Physiol online 6(4):24–33
- NBJ (2009) Sports nutrition & weight loss report. Nutrition Business Journal, vol XIV, September edn., Boulder
- Shimizu T (2008) Korean latest conditions of health food labeling. Food Style 12(1):54–56
Cited by
Kreider, R. B., Kalman, D. S., Antonio, J., Ziegenfuss, T. N., Wildman, R., Collins, R., Candow, D. G., Kleiner, S. M., Almada, A. L., & Lopez, H. L. (2017) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-017-0173-z · Cited by 1,057
“Creatine is found in high amounts in the food supply and therefore its use is not banned by any sport organization although some organizations prohibit provision of some types of dietary supplements to athletes by their teams [5, 53, 78, 91, 92].”
BackgroundInfluentialSelf-citationWu, G. (2020) · Amino Acids · doi:10.1007/s00726-020-02823-6 · Cited by 475
Creatine supplementation with specific view to exercise/sports performance: An update
Cooper, R., Naclerio, F., Allgrove, J., & Jimenez, A. (2012) · Journal of the International Society of Sports Nutrition · doi:10.1186/1550-2783-9-33 · Cited by 306
Antonio, J., Candow, D. G., Forbes, S. C., Gualano, B., Jagim, A. R., Kreider, R. B., Rawson, E. S., Smith-Ryan, A. E., VanDusseldorp, T. A., Willoughby, D. S., et al. (2021) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-021-00412-w · Cited by 345
“Creatine monohydrate powder is very stable showing no signs of degradation into creatinine over years, even at elevated storage temperatures [187].”
BackgroundInfluentialSelf-citationCreatine in health and disease
Kreider, R. B., & Stout, J. R. (2021) · Nutrients · doi:10.3390/nu13020447 · Cited by 227
Self-citation
Metadata
- Authors
- Jäger, R., Purpura, M., Shao, A., Inoue, T., & Kreider, R. B.
- Affiliations
- Increnovo LLC (United States) (US)
- Texas A&M University (US)
- Corresponding author
- Kreider, Richard B.
- Venue
- Amino Acids
- Published
- 2011-03-22
- Volume
- 40
- Issue
- 5
- Pages
- 1369-1383
- ISSN
- 0939-4451 (ISSN-L)
- 1438-2199
- PMC
- PMC3080578
- OpenAlex
- W2137242866
- Cited by
- 181
- References
- 75
- Citations by year
- 2026: 16 · 2025: 18 · 2024: 22 · 2023: 13 · 2022: 19 · 2021: 16 · 2020: 9 · 2019: 9 · 2018: 12 · 2017: 5 · 2016: 8 · 2015: 11 · 2014: 11 · 2013: 6 · 2012: 5
- FWCI
- 0.63
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Amino Acids (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
- Health Sciences › Medicine › Physiology (medical) › Biochemical effects in animals
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutrition and Health Studies
- Keywords
- creatine, creatine monohydrate, sports nutrition, dietary supplements, bioavailability, supplement efficacy, supplement safety, regulatory status, phosphocreatine, muscle creatine, anaerobic exercise performance, muscle mass
- MeSH terms
- Creatine, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-31, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-31 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Analysis of the efficacy, safety, and regulatory status of novel forms of creatine. https://app.cochat.ai/papers/10.1007/s00726-011-0874-6
- The paper
- Jäger, R., Purpura, M., Shao, A., Inoue, T., & Kreider, R. B. (2011). Analysis of the efficacy, safety, and regulatory status of novel forms of creatine. Amino Acids. https://doi.org/10.1007/s00726-011-0874-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.